{"id":1002,"date":"2025-07-04T11:34:00","date_gmt":"2025-07-04T09:34:00","guid":{"rendered":"https:\/\/lensounds.com\/2025\/07\/04\/framatome-installe-un-premier-site-de-production-de-radio-isotopes-a-nantes\/"},"modified":"2026-03-05T16:37:25","modified_gmt":"2026-03-05T15:37:25","slug":"framatome-installs-first-radioisotope-production-site-nantes","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/","title":{"rendered":"FRAMATOME INSTALLS FIRST RADIOISOTOPE PRODUCTION SITE IN NANTES"},"content":{"rendered":"<p><strong>Les Echos<\/strong> \u2013 SME-Regions \/ Innovators<br \/>By Emmanuel Guimard \u2013 July 4, 2025<\/p>\n<p>The nuclear energy specialist will invest \u20ac20 to \u20ac30 million in a first production capacity for astatine-211, a promising radionuclide in the fight against cancer. This facility is expected to be operational in 2027 or 2028.<\/p>\n<p>Framatome is stepping up its presence in nuclear medicine. The French group announces the installation of an astatine-211 production unit in Saint-Herblain (Loire-Atlantique), near Nantes. Framatome Healthcare is partnering with Belgian company IBA to design the cyclotron required for manufacturing this radioisotope.<\/p>\n<h3>Reference<\/h3>\n<p><strong>Source:<\/strong> Les Echos, SME-Regions \/ Innovators<\/p>\n<p><strong>Author:<\/strong> Emmanuel Guimard<\/p>\n<p><strong>Date:<\/strong> July 4, 2025<\/p>\n<p><strong>Link to original article:<\/strong> <a href=\"https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/framatome-installe-un-premier-site-de-production-de-radio-isotopes-a-nantes-2174796\" target=\"_blank\" rel=\"noopener\">www.lesechos.fr<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les Echos \u2013 SME-Regions \/ InnovatorsBy Emmanuel Guimard \u2013 July 4, 2025 The nuclear energy specialist will invest \u20ac20 to \u20ac30 million in a first production capacity for astatine-211, a promising radionuclide in the fight against cancer. This facility is expected to be operational in 2027 or 2028. Framatome is stepping up its presence in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1004,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[47],"tags":[],"class_list":["post-1002","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Framatome Installs First Radioisotope Production Site in Nantes<\/title>\n<meta name=\"description\" content=\"Framatome opens France&#039;s first astatine-211 radioisotope production facility in Nantes, advancing targeted cancer therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Framatome Installs First Radioisotope Production Site in Nantes\" \/>\n<meta property=\"og:description\" content=\"Framatome opens France&#039;s first astatine-211 radioisotope production facility in Nantes, advancing targeted cancer therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-04T09:34:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T15:37:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/framatome.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"410\" \/>\n\t<meta property=\"og:image:height\" content=\"240\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin27\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin27\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/\"},\"author\":{\"name\":\"admin27\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"headline\":\"FRAMATOME INSTALLS FIRST RADIOISOTOPE PRODUCTION SITE IN NANTES\",\"datePublished\":\"2025-07-04T09:34:00+00:00\",\"dateModified\":\"2026-03-05T15:37:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/\"},\"wordCount\":107,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/framatome.jpg\",\"articleSection\":[\"Other news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/\",\"name\":\"Framatome Installs First Radioisotope Production Site in Nantes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/framatome.jpg\",\"datePublished\":\"2025-07-04T09:34:00+00:00\",\"dateModified\":\"2026-03-05T15:37:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"description\":\"Framatome opens France's first astatine-211 radioisotope production facility in Nantes, advancing targeted cancer therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/framatome.jpg\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/framatome.jpg\",\"width\":410,\"height\":240},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/07\\\/04\\\/framatome-installs-first-radioisotope-production-site-nantes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FRAMATOME INSTALLS FIRST RADIOISOTOPE PRODUCTION SITE IN NANTES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\",\"name\":\"admin27\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"caption\":\"admin27\"},\"sameAs\":[\"https:\\\/\\\/pulsheart-medical.com\"],\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/admin27\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Framatome Installs First Radioisotope Production Site in Nantes","description":"Framatome opens France's first astatine-211 radioisotope production facility in Nantes, advancing targeted cancer therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/","og_locale":"en_US","og_type":"article","og_title":"Framatome Installs First Radioisotope Production Site in Nantes","og_description":"Framatome opens France's first astatine-211 radioisotope production facility in Nantes, advancing targeted cancer therapies.","og_url":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/","og_site_name":"Atonco","article_published_time":"2025-07-04T09:34:00+00:00","article_modified_time":"2026-03-05T15:37:25+00:00","og_image":[{"width":410,"height":240,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/framatome.jpg","type":"image\/jpeg"}],"author":"admin27","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin27","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/"},"author":{"name":"admin27","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"headline":"FRAMATOME INSTALLS FIRST RADIOISOTOPE PRODUCTION SITE IN NANTES","datePublished":"2025-07-04T09:34:00+00:00","dateModified":"2026-03-05T15:37:25+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/"},"wordCount":107,"commentCount":0,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/framatome.jpg","articleSection":["Other news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/","url":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/","name":"Framatome Installs First Radioisotope Production Site in Nantes","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/framatome.jpg","datePublished":"2025-07-04T09:34:00+00:00","dateModified":"2026-03-05T15:37:25+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"description":"Framatome opens France's first astatine-211 radioisotope production facility in Nantes, advancing targeted cancer therapies.","breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/framatome.jpg","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/framatome.jpg","width":410,"height":240},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2025\/07\/04\/framatome-installs-first-radioisotope-production-site-nantes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"FRAMATOME INSTALLS FIRST RADIOISOTOPE PRODUCTION SITE IN NANTES"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5","name":"admin27","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","caption":"admin27"},"sameAs":["https:\/\/pulsheart-medical.com"],"url":"https:\/\/atonco-pharma.com\/en\/author\/admin27\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1002"}],"version-history":[{"count":2,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1002\/revisions"}],"predecessor-version":[{"id":1011,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1002\/revisions\/1011"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1004"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}